{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:56:28Z","timestamp":1789167388110,"version":"build-2803163510"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:sec id=\"ab-eoi240029-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>National estimates regarding the frequency of presentations and patterns of care for eye pain are unknown. This information could guide research and clinical efforts to optimize outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240029-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate eye pain visits in the US in the outpatient and emergency department (ED) settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240029-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This retrospective cross-sectional study of National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data (2008-2019) analyzed a population-based sample of visits to outpatient clinics and EDs. The sample consisted of patients presenting with eye pain. Data were analyzed from September 2023 to April 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240029-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Weighted sample data estimated outpatient and ED eye pain presentations including patient and clinician characteristics, diagnoses (\n                      <jats:italic>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision [ICD-10]<\/jats:italic>\n                      ), and disposition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240029-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2008 through 2019, 4.6 million (95% CI, 3.9 million to 5.3 million) outpatient and 1.0 million (95% CI, 0.8 million to 1.1 million) ED eye pain visits occurred annually. Patients were predominantly women (63.2% [95% CI, 59.4%-67.0%]) and older than 60 years (46.6% [95% CI, 42.4%-51.0%]) in the outpatient setting. Patients presenting to the ED were more often men (51.8% [95% CI, 48.7%-55.0%]) and aged younger than 45 years (aged &amp;amp;lt;15 years: 16.4% [95% CI, 13.9%-18.8%]; 15-24 years: 19.2% [95% CI, 16.6%-21.7%]; and 25-44 years: 35.6% [95% CI, 32.7%-38.5%]). In nearly half of outpatient eye pain visits, the major problem was classified as nonacute (2.0 million [95% CI, 1.6 million to 2.3 million]). Eye pain was the primary reason for the visit (RFV) in 42.0% (95% CI, 37.8%-46.2%) of outpatient visits and 66.9% (95% CI, 62.9%-70.9%) of ED eye pain visits. It was the only RFV in 18.3% (95% CI, 15.0%-21.7%) of outpatient and 32.7% (95% CI, 29.0%-36.4%) of ED eye pain encounters. Ophthalmologists evaluated the largest number of outpatient visits (45.3% [95% CI, 38.8%-51.7%). The primary diagnosis was non\u2013vision threatening for most outpatient (78.5% [95% CI, 56.8%-100%]) and ED (69.9% [95% CI, 62.1%-77.7%]) visits when eye pain was the primary RFV. Additional follow-up was scheduled in 89.4% (95% CI, 86.2%-92.6%) of visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240029-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>More than 5 million eye pain visits occur annually; the largest percentage are outpatient with ophthalmologists. Most diagnoses were non\u2013vision threatening in both the outpatient and ED setting and resulted in additional care. Expanding therapeutic approaches to treat the causes of eye pain may reduce the burden on the health care system and optimize outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.1808","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:33:00Z","timestamp":1717673580000},"page":"655","source":"Crossref","is-referenced-by-count":11,"title":["Health Care Use for Eye Pain"],"prefix":"10.1001","volume":"142","author":[{"given":"Jeremy N.","family":"Shapiro","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebhi O.","family":"Abuzaitoun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Woodward","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Clauw","sequence":"additional","affiliation":[{"name":"Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni M.","family":"Shtein","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey B.","family":"De Lott","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"eoi240029r1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1167\/iovs.03-0915","article-title":"The relative burden of dry eye in patients\u2019 lives: comparisons to a US normative sample.","volume":"46","author":"Mertzanis","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi240029r3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199131","article-title":"Association between dry eye symptoms and suicidal ideation in a Korean adult population.","volume":"13","author":"Um","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"eoi240029r4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis.","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"issue":"2","key":"eoi240029r5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1177\/1120672120907315","article-title":"Economic impact of dry eye disease in Spain: a multicentre retrospective insurance claims database analysis.","volume":"31","author":"Darb\u00e0","year":"2021","journal-title":"Eur J Ophthalmol"},{"issue":"14","key":"eoi240029r6","doi-asserted-by":"publisher","first-page":"DES1","DOI":"10.1167\/iovs.17-23491","article-title":"What we know about the epidemiology of dry eye disease in Japan.","volume":"59","author":"Uchino","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi240029r9","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0161-6420(98)96016-X","article-title":"The epidemiology of dry eye in Melbourne, Australia.","volume":"105","author":"McCarty","year":"1998","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240029r10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","article-title":"Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study.","volume":"31","author":"Chia","year":"2003","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"eoi240029r11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index.","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"eoi240029r12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(03)00218-6","article-title":"Prevalence of dry eye syndrome among US women.","volume":"136","author":"Schaumberg","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi240029r13","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/archophthalmol.2009.103","article-title":"Prevalence of dry eye disease among US men: estimates from the Physicians\u2019 Health Studies.","volume":"127","author":"Schaumberg","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"eoi240029r14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/ACI.0000000000000389","article-title":"Neuropathic symptoms of the ocular surface: dryness, pain, and itch.","volume":"17","author":"Andersen","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"12","key":"eoi240029r15","first-page":"2469","article-title":"Self-reported assessment of dry eye in a population-based setting.","volume":"38","author":"Bandeen-Roche","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"eoi240029r16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaophthalmol.2015.5778","article-title":"Epidemiology of eye-related emergency department visits.","volume":"134","author":"Channa","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"eoi240029r17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/archopht.123.5.662","article-title":"Incidence of emergency department-treated eye injury in the United States.","volume":"123","author":"McGwin","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"eoi240029r2","unstructured":"Shtein? RM, Harper? DE, Pallazola? V, . Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2016;114:T4."},{"key":"eoi240029r7","unstructured":"US Centers for Disease Control and Prevention. Ambulatory health care data: questionnaires, datasets, and related documentation. Accessed June 2, 2017. https:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_questionnaires.htm"},{"key":"eoi240029r8","unstructured":"US Centers for Disease Control and Prevention. 2020 NAMCS public use data file update. Accessed November 16, 2023. https:\/\/www.cdc.gov\/nchs\/ahcd\/notice.htm"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2819802\/jamaophthalmology_shapiro_2024_oi_240029_1719935951.11499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T11:03:59Z","timestamp":1721300639000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2819802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.1808","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}